A gene therapy trial for the fatal disorder Duchenne muscular dystrophy (DMD) is about to begin in London.In a world first, a small group of patients will be injected with an experimental drug which it is hoped will extend their lives.
A gene therapy trial for the fatal disorder Duchenne muscular dystrophy (DMD) is about to begin in London.In a world first, a small group of patients will be injected with an experimental drug which it is hoped will extend their lives.
